RenovoRx presents data from Trans-Arterial Micro-Perfusion therapy platform
RenovoRx (RNXT) highlighted its recent abstract presentation at the 2025 Society of Interventional Oncology Annual Conference in Las Vegas, ...
Le Lézard16h
RenovoRx Highlights Promising Pre-Clinical Data Abstract: TAMPtm Therapy Platform Offers Potential to Improve Localized and Targeted Drug Delivery
RenovoRx, Inc. ("RenovoRx" or the "Company") , a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath, an innovative, FDA-cleared device, highlighted its ...
RenovoRx Highlights Promising Pre-Clinical Data Abstract: TAMP™ Therapy Platform Offers Potential to Improve Localized and Targeted Drug Delivery
RenovoRx, Inc. ("RenovoRx" or the "Company") (Nasdaq: RNXT), a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath, an innovative, FDA-cleared device, ...
GP magazine2d
ACE inhibitors and renal artery stenosis
Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...